Motilal Oswal's research report on SRF
The Kigali Amendment categorizes countries into Non-Article 5 (developed nations) and Article 5 (developing nations, split into Group 1 and Group 2) with differentiated baseline periods and freeze years. For India (A5 Group 2), the baseline is the average of CY24-26 plus 65% of HCFC usage, with CY28 as the freeze year.
Outlook
Asia is expected to remain the key growth driver for HFC demand as developed nations transition to lower-GWP alternatives. With HCFC consumption concentrated in Asia, the region particularly India is poised for incremental growth, driven by the ongoing shift from HCFCs to HFCs and regulatory controls on trade. We expect SRF to post a CAGR of 16%/30%/42% in revenue/EBITDA/adjusted PAT over FY25-27. We reiterate BUY with our FY27 SoTP-based TP of INR 3,650.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
